Mesoblast's Cell Therapy Strengthens Native Heart Function In Patients With End-Stage Heart Failure on Assisted Circulatory Support
18 nov. 2013 18h14 HE
|
Mesoblast
NEW YORK and MELBOURNE, Australia, Nov. 18, 2013 (GLOBE NEWSWIRE) -- Patients with end-stage or New York Heart Association (NYHA) class IV heart failure who receive a surgically implanted left...
Battelle Continues Data Coordination Center Work for TMD Cooperative Agreement
02 oct. 2013 10h20 HE
|
Battelle
COLUMBUS, OH--(Marketwired - Oct 2, 2013) - Battelle has won a $5.2 million follow-on contract to serve as the data coordination center for a series of important studies led by the University of...
HHS Secretary Kathleen Sebelius Appoints AmeriHealth Caritas President and CEO Michael A. Rashid to National Advisory Council on Minority Health and Health Disparities
12 sept. 2013 13h13 HE
|
Amerihealth Mercy Family
PHILADELPHIA, Sept. 12, 2013 (GLOBE NEWSWIRE) -- Michael A. Rashid, president and chief executive officer of AmeriHealth Caritas Family of Companies, a national leader in Medicaid managed care and...
The Lupus Initiative Unveils Free Curriculum and Education Materials to Advance Care for Patients Fighting Devastating Autoimmune Disease
16 mai 2013 10h50 HE
|
American College of Rheumatology
WASHINGTON, May 16, 2013 (GLOBE NEWSWIRE) -- The Lupus Initiative, a national provider education program led by the American College of Rheumatology, today announced a new easy-to-use curriculum and...
Xeris Pharmaceuticals Closed 2012 with $6M In Additional Funding
11 févr. 2013 09h42 HE
|
Xeris Pharmaceuticals, Inc.
Austin, TX, Feb. 11, 2013 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. ("Xeris"), an Austin-based, emerging
pharmaceutical company developing patient-friendly injectable
treatments for diabetes,...
eMedonline(R) Receives NIH Grant to Expand mHealth Platform on iPhone and Android to Improve Medication Adherence and Reduce Hospital Readmissions
18 sept. 2012 06h00 HE
|
Leap of Faith Technologies, Inc.
CHICAGO, Sept. 18, 2012 (GLOBE NEWSWIRE) -- The National Institutes of Health (NIH), National Cancer Institute (NCI) has awarded Leap of Faith Technologies® a $1,021,296 grant to further develop...
Xeris Pharmaceuticals Awarded Phase I-II NIH SBIR Fast Track Grant to Advance Stable, Non-Aqueous Glucagon for Bi-Hormonal Artificial Pancreas
31 juil. 2012 10h41 HE
|
Xeris Pharmaceuticals, Inc.
Austin, TX, July 31, 2012 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. ("Xeris"), an Austin-based, emerging
biopharmaceutical company developing patient-friendly injectable
treatments for diabetes...
Battelle Wins $102M NIAID Biodefense Research Contract
18 juil. 2012 10h30 HE
|
Battelle
COLUMBUS, OH--(Marketwire - Jul 18, 2012) - Battelle has won a single-source award from the U.S. Department of Health and Human Services' National Institutes of Health for evaluation and testing...